Publication | Open Access

Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs)

MedicineReceptor Tyrosine KinasePathologyPrimary ResistanceBronchial NeoplasmTyrosine Kinase InhibitorsCancer GenomicsMolecular DiagnosticsOncologyRadiation OncologyLung CancerTumor BiologyPotential Resistance Mechanisms